908 Devices (MASS) Cash & Equivalents (2020 - 2026)
908 Devices' (MASS) quarterly Cash & Equivalents came in at $67.6 million in Q1 2026, down 14.65% year-on-year from $79.2 million in Q1 2025, and down 4.19% on a QoQ basis from $70.5 million in Q4 2025.
908 Devices (MASS) Cash & Equivalents (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Cash & Equivalents data on file, last reported at $67.6 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 14.65% year-over-year to $67.6 million in Q1 2026; TTM through Mar 2026 was $67.6 million, a 14.65% decrease from a year earlier, with the FY2025 full-year figure at $70.5 million, up 62.65% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $67.6 million, down from $70.5 million in the prior quarter.
- Over the last five years, Cash & Equivalents for MASS reached as high as $223.1 million in Q1 2022 and fell as low as $43.4 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $113.7 million across 5 years, with a median of $104.6 million in 2024.
- Across the five-year window, Cash & Equivalents tumbled 64.8% in 2024 and surged 62.65% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $188.4 million in 2022, then sank by 35.76% to $121.0 million in 2023, then plunged by 64.18% to $43.4 million in 2024, then jumped by 62.65% to $70.5 million in 2025, then decreased by 4.19% to $67.6 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $67.6 million in Q1 2026, $70.5 million in Q4 2025, and $62.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn | 67.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.56 Mn |
| Dec 31, 2025 | 70.52 Mn |
| Sep 30, 2025 | 62.80 Mn |
| Jun 30, 2025 | 61.75 Mn |
| Mar 31, 2025 | 79.16 Mn |
| Dec 31, 2024 | 43.36 Mn |
| Sep 30, 2024 | 45.03 Mn |
| Jun 30, 2024 | 46.81 Mn |
| Mar 31, 2024 | 104.60 Mn |
| Dec 31, 2023 | 121.04 Mn |
| Sep 30, 2023 | 118.21 Mn |
| Jun 30, 2023 | 133.00 Mn |
| Mar 31, 2023 | 161.21 Mn |
| Dec 31, 2022 | 188.42 Mn |
| Sep 30, 2022 | 193.70 Mn |
| Jun 30, 2022 | 212.99 Mn |
| Mar 31, 2022 | 223.12 Mn |
| Dec 31, 2021 | 224.07 Mn |
| Sep 30, 2021 | 138.82 Mn |
| Jun 30, 2021 | 141.31 Mn |